Current evidence suggests these are long-term treatments, similar to blood pressure or cholesterol medications
We are hopeful about the potential to bring a first-of-its-kind treatment option to people living with moderate-to-severe OSA and obesity, who currently have no pharmaceutical treatments for the underlying disease, says a spokesperson for Eli Lilly
For those considering this option, understanding the science and potential benefits can help in making informed decisions and achieving lasting health goals
That usually means prioritizing protein and filling predictable micronutrient gaps with clinician-informed supplements that fit real life
Sobobas focus on in-person care, physician guidance, and ongoing support positions the clinic as a strong local option for Ozempic weight-loss treatment
Ozempic (semaglutide) is FDA-approved for type 2 diabetes management and has extensive real-world usage data